When Alexander Fleming discovered pencillin in 1928 he could hardly have imagined that one day the world would be battling drug resistant superbugs with genes like New Delhi metallo-beta-lactamase (NDM-1), which can render the most intensive antibiotic treatments ineffective.

About 4.4 lakh new cases of multidrug-resistant tuberculosis emerge annually, causing at least 1.5 lakh deaths.